Publications

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.

Author(s): Mack CD, DiFiori J, Tai CG, Shiue KY, Grad YH, Anderson DJ, Ho DD, Sims L, LeMay C, Mancell J, Maragakis LL|Journal: JAMA Intern Med|PMID: 33885715| April 2021

Clinical data are lacking regarding the risk of viral transmission from individuals who have positive reverse-transcription-polymerase chain reaction (RT-PCR) SARS-CoV-2…

A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch.

Author(s): Sánchez-Busó L, Yeats CA, Taylor B, Goater RJ, Underwood A, Abudahab K, Argimón S, Ma KC, Mortimer TD, Golparian D, Cole MJ, Grad YH, Martin I, Raphael BH, Shafer WM, Town K, Wi T, Harris SR, Unemo M, Aanensen DM|Journal: Genome Med|PMID: 33875000| April 2021

Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.

Author(s): Cobey S, Larremore DB, Grad YH, Lipsitch M|Journal: Nat Rev Immunol|PMID: 33795856| April 2021

When vaccines are in limited supply, expanding the number of people who receive some vaccine, such as by halving doses…

Reduction in antibiotic prescribing attainable with a gonococcal vaccine.

Author(s): Kissler SM, Mitchell M, Grad YH|Journal: Clin Infect Dis|PMID: 33786582| March 2021

We estimated the fraction of antibiotic prescribing in the US attributable to gonorrhea. Gonorrhea contributes to an outsized proportion of…

Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae.

Author(s): Yahara K, Ma KC, Mortimer TD, Shimuta K, Nakayama SI, Hirabayashi A, Suzuki M, Jinnai M, Ohya H, Kuroki T, Watanabe Y, Yasuda M, Deguchi T, Eldholm V, Harrison OB, Maiden MCJ, Grad YH, Ohnishi M|Journal: Genome Med|PMID: 33785063| March 2021

Antimicrobial resistance in Neisseria gonorrhoeae is a global health concern. Strains from two internationally circulating sequence types, ST-7363 and ST-1901,…

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys.

Author(s): Larremore DB, Fosdick BK, Bubar KM, Zhang S, Kissler SM, Metcalf CJE, Buckee C, Grad YH|Journal: Elife|PMID: 33666169| March 2021

Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests…

GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies.

Author(s): Brown TS, Martinez de Salazar Munoz P, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb A, Naranbai V, Garcia Beltran W, Miller TE, Thierauf J, Yang W, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH|Journal: medRxiv|PMID: 33564784| February 2021

Tracking the dynamics and spread of COVID-19 is critical to mounting an effective response to the pandemic. In the absence…

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.

Author(s): Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB|Journal: Science|PMID: 33479118| January 2021

Limited initial supply of SARS-CoV-2 vaccine raises the question of how to prioritize available doses. Here, we used a mathematical…

Optimal design for phase 2 studies of SARS-CoV-2 antiviral drugs

Author(s): Watson JA, Kissler S, Day NP, Grad YH, White NJ|Journal: medRxiv| January 2021

There is no agreed methodology for pharmacometric assessment of candidate antiviral drugs in COVID-19. The most widely used measure of…

Large variation in the association between seasonal antibiotic use and resistance across multiple bacterial species and antibiotic classes

Author(s): Sun DS, Kissler SM, Kanjilal S, Olesen SW, Lipsitch M, Grad YH|Journal: medRxiv| December 2020

Understanding how antibiotic use drives resistance is crucial for guiding effective strategies to limit the spread of resistance, but the…